| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Burton Daniel D. | Chief Executive Officer, Director | C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN | /s/ Benjamin Landry, as Attorney-in-Fact | 03 Dec 2025 | 0001780980 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HCAT | Common Stock | Tax liability | -$162K | -55.7K | -3.85% | $2.90 | 1.39M | 01 Dec 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |